3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
58
Multiple Myeloma
52
Leukemia
48
Leukemia, Myeloid, Acute
44
Precursor Cell Lymphoblastic Leukemia-Lymphoma
41
Myelodysplastic Syndromes
37
Lymphoma, Non-Hodgkin
37
Hodgkin Disease
36
Lymphoma, Mantle-Cell
26
Lymphoma, Large B-Cell, Diffuse
26
Leukemia, Lymphocytic, Chronic, B-Cell
25
Lymphoma, Follicular
22
Breast Neoplasms
22
Burkitt Lymphoma
21
Lymphoma, B-Cell, Marginal Zone
16
Congenital Abnormalities
15
Lymphoma, Large-Cell, Immunoblastic
14
Recurrence
13
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
13
Sarcoma
12
Neoplasms, Plasma Cell
12
Hematologic Neoplasms
10
Leukemia, Myelomonocytic, Juvenile
9
Leukemia, Biphenotypic, Acute
9
Blast Crisis
9
Neoplasms
8
Myeloproliferative Disorders
8
Leukemia, Myelomonocytic, Chronic
8
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
7
Neuroblastoma
7
Interventions
Darbepoetin alfa
2
piperine
1
fludarabine phosphate
1
ferrous sulfate
1
ferric gluconate
1
Whole-Body Irradiation
1
Urination
1
Therapeutics
1
Sucrose
1
Rituximab
1
Phenytoin
1
Peripheral Blood Stem Cell Transplantation
1
Oxycodone
1
Mycophenolic Acid
1
Morphine
1
Methotrexate
1
Methadone
1
Metformin
1
KW-2478
1
Hsp90 inhibitor KU757
1
Granulocyte Colony-Stimulating Factor
1
Gene Expression Profiling
1
Fentanyl
1
Fatty Acids, Omega-3
1
Epoetin Alfa
1
Early Intervention, Educational
1
Cyclosporine
1
Curcumin
1
Celecoxib
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Monoclonal Gammopathy of Undetermined Significance
×
Filgrastim
×
Clear all
No trials found.